The goal of this activity is for learners to be better able to understand the latest clinical data with novel therapies in Epidermolysis bullosa (EB), identify which patients might benefit from these emerging treatments as well as assess where these novel therapies fit into the current treatment algorithm.
- Provider:Medscape, LLC
- Activity Link: https://www.medscape.org/viewarticle/1000534
- Start Date: 2024-03-28 05:00:00
- End Date: 2024-03-28 05:00:00
- Credit Details: IPCE Credits: 0.5 hours
AMA PRA Category 1 Credit™️: 0.5 hours
Nursing: 0.5 hours - Commercial Support: Source: Chiesi Farmaceutici S.P.A. - Amount: 188000.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest